Nicox Launches New Corporate & Investor Website
10/04/2021
Nicox SA announced the launch of its redesigned corporate and investor website. The new corporate website, www.nicox.com, features:
- New visual image for Nicox
- Introductory video on the company
- Mechanism-of-action video on NCX 470, our lead product candidate in glaucoma
- New layout and easier access to key information on the company
Nicox is an international ophthalmology company with two product candidates in clinical development—one in phase 3 in glaucoma and another one in phase 2b in blepharitis—and recurrent licensing revenue from partners on two commercialized products.